{"url_path":"/sec/cpmd/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1081938/0001654954-26-005180-index.html","accession_number":"0001654954-26-005180","cik":"0001081938","ticker":"CPMD","issuer_name":"CANNAPHARMARX, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1081938/0001654954-26-005180-index.html","primary_entity_key":"0001081938","primary_entity_name":"CANNAPHARMARX, INC."},"word_count":382,"has_tables":true,"body_markdown":"**ITEM 6. EXHIBITS**\n\n \n\n2.1\n\nAmended and Restated Membership Interest Purchase Agreement, dated November 22, 2023\n\n3.1\n\nBylaws adopted 12/31/10\n\n3.2\n\nCertificate of Amendment of Certificate of Incorporation dated 10/22/14\n\n3.3\n\nCertificate of Designation of Preferences, Rights and Limitation of Series C Convertible Preferred Stock\n\n4.1\n\nLetter Agreement between the Company and Koze Investments, LLC and Amir Tal regarding Allocation of Revenue from IMC Cannabis Transaction dated March 17, 2025\n\n4.2\n\nSecurity And Royalty Agreement between the Company and Koze Investments, LLC dated March 17, 2025\n\n4.3\n\nAmended and Restated Lease dated January 1, 2025\n\n4.4\n\nAmendment No. 1 to Amended and Restated Secured Promissory Note; entered into with Koze Investments LLC and Amir Tal\n\n4.5\n\nAmendment No. 1 to Amended and Restated Senior Secured Promissory Note; entered into with Koze Investments\n\n4.6\n\nSecured Promissory Note dated February 26, 2025\n\n4.7\n\nTransfer of 2323414 Alberta Ltd. to Elliot Zemel dated March 17, 2025\n\n4.8\n\nForbearance Agreement 2323414 Alberta (CPMD) - Formosa (June 2025)\n\n4.9\n\nLetter Agreement (Payment Schedule) - A. Tal\n\n4.10\n\nPayment Schedule (Payment Schedule) - Koze Investments\n\n[31.1](canna_ex311.htm)\n\n[Certification of Chief Executive Officer required by Rule 13a-14(a) under the Exchange Act (filed herewith).](canna_ex311.htm)\n\n[31.2](canna_ex312.htm)\n\n[Certification of Chief Financial Officer required by Rule 13a-14(a) under the Exchange Act (filed herewith).](canna_ex312.htm)\n\n[32](canna_ex32.htm)\n\n[Certification of Principal Executive, Financial and Accounting Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002 (filed herewith).](canna_ex32.htm)\n\n101.INS\n\nInline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are\n\nembedded within the Inline XBRL document)\n\n101.SCH\n\nInline XBRL Taxonomy Extension Schema Document\n\n101.CAL\n\nInline XBRL Taxonomy Extension Calculation Linkbase Document\n\n101.DEF\n\nInline XBRL Taxonomy Extension Definition Linkbase Document\n\n101.LAB\n\nInline XBRL Taxonomy Extension Label Linkbase Document\n\n101.PRE\n\nInline XBRL Taxonomy Extension Presentation Linkbase Document\n\n104\n\nCover Page Interactive Data File (formatted in IXBRL, and included in exhibit 101)\n\n \n\n \n\n31\n\n*Table of Contents*\n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of Section 12 of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized on May 20, 2026.\n\n \n\n \n\n**CannaPharmaRx, Inc.**\n\n \n\n \n\n \n\n \n\n \n\n \n\nBy:\n\n/s/ Constantine Nkafu\n\n \n\n \n\n \n\nConstantine Nkafu,\n\n \n\n \n\n \n\nChief Executive Officer\n\n \n\n \n\n \n\n \n\n \n\n \n\nBy:\n\n/s/ Oliver Foeste\n\n \n\n \n\n \n\nOliver Foeste,\n\n \n\n \n\n \n\nChief Financial Officer\n\n \n\n \n\n \n\n32"}